Gilde Healthcare Holding B.V.

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused exclusively on the shoulder surgical care market. The company offers advanced implant systems for shoulder arthroplasty, which is a surgical procedure to reconstruct the shoulder joint using prosthetic implants. This procedure is performed using two main approaches: anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA). Both aTSA and rTSA can be performed in inpatient hospital settings and in outpatient settings, including Ambulatory Surgical Centers (ASCs). These implant systems are a core part of Shoulder Innovations' ecosystem, which is designed to improve preoperative planning, implant design, and procedural efficiency in shoulder surgical care. The ecosystem also includes enabling technologies, efficient instrument systems, specialized support, and surgeon-to-surgeon collaboration. The company aims to address clinical and operational challenges in the shoulder surgical care market by providing predictable outcomes, procedural simplicity, and efficiency across all care sites. Shoulder pain, often chronic, results from conditions such as osteoarthritis, rheumatoid arthritis, rotator cuff tears, and shoulder fractures. These conditions are widespread and, according to data from the National Institutes of Health, are estimated to result in more than eight million physician visits annually in the United States. Shoulder Innovations believes there has been historical underutilization of surgical treatments for shoulder care due to factors like patient hesitation, insufficient technology, complex shoulder anatomy, perceived difficulty of surgery, and barriers to patient access. The company's initial focus within this market is on shoulder arthroplasty.